83 FR 43692 - Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 166 (August 27, 2018)

Page Range		43692-43693
FR Document		2018-18483

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). The meeting will be open to the public; a public comment session will be held during the meeting. Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or send in their public comment via email should send an email to [email protected] Registration information is available on the website http://www.hhs.gov/ash/carb/ and must be completed by September 19, 2018; all in-person attendees must pre-register by this date. Additional information about registering for the meeting and providing public comment can be obtained at http://www.hhs.gov/ash/carb/ on the Meetings page.

Federal Register, Volume 83 Issue 166 (Monday, August 27, 2018)

[Federal Register Volume 83, Number 166 (Monday, August 27, 2018)]
[Notices]
[Pages 43692-43693]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-18483]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held for the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). 
The meeting will be open to the public; a public comment session will 
be held during the meeting. Pre-registration is required for members of 
the public who wish to attend the meeting and who wish to participate 
in the public comment session. Individuals who wish to attend the 
meeting and/or send in their public comment via email should send an 
email to [email protected]. Registration information is available on the 
website http://www.hhs.gov/ash/carb/ and must be completed by September 
19, 2018; all in-person attendees must pre-register by this date. 
Additional information about registering for the meeting and providing 
public comment can be obtained at http://www.hhs.gov/ash/carb/ on the 
Meetings page.

DATES: The meeting is scheduled to be held on September 26, 2018, from 
9:00 a.m. to 5:00 p.m. ET (times are tentative and subject to change). 
The confirmed times and agenda items for the meeting will be posted on 
the website for the Advisory Council at http://www.hhs.gov/ash/carb/ 
when this information becomes available. Pre-registration for attending 
the meeting in person is required to be completed no later than 
September 19, 2018; public attendance at the meeting is limited to the 
available space.

ADDRESSES: This public meeting is being held at the Sheraton Columbus 
Hotel at Capitol Square, 75 East State Street, Columbus, OH, 43215. The 
meeting can also be accessed through a live webcast on the day of the 
meeting. For more information, visit http://www.hhs.gov/ash/carb/.

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, Acting Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Room 715H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of HHS to establish the 
Advisory Council, in consultation with the Secretaries of Defense and 
Agriculture. Activities of the Advisory Council are governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets 
forth standards for the formation and use of federal advisory 
committees.
    The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to support and evaluate the implementation of Executive Order 
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating 
Antibiotic-Resistant Bacteria. The Advisory Council shall function 
solely for advisory purposes.
    In carrying out its mission, the Advisory Council will provide 
advice, information, and recommendations to the Secretary regarding 
programs and policies intended to preserve the effectiveness of 
antibiotics by optimizing their use; advance research to develop 
improved methods for combating antibiotic resistance and conducting 
antibiotic stewardship; strengthen surveillance of antibiotic-resistant 
bacterial infections; prevent the transmission of antibiotic-resistant 
bacterial infections; advance the development of rapid point-of-care 
and agricultural diagnostics; further research on new treatments for 
bacterial infections; develop alternatives to antibiotics for 
agricultural purposes; maximize the dissemination of up-to-date 
information on the appropriate and proper use of antibiotics to the 
general public and human and animal healthcare providers; and improve 
international coordination of efforts to combat antibiotic resistance.
    The September 26, 2018, public meeting will be dedicated to the 
Advisory Council's deliberation and vote of the Infection Prevention 
and Stewardship Working Group's draft report with recommendations, in 
addition to other topic areas surrounding antibiotic-resistance and One 
Health. The meeting agenda will be posted on the Advisory Council 
website at http://www.hhs.gov/ash/carb/ when it has been finalized. All 
agenda items are tentative and subject to change.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Advisory Council at the

[[Page 43693]]

address/telephone number listed above at least one week prior to the 
meeting. For those unable to attend in person, a live webcast will be 
available. More information on registration and accessing the webcast 
can be found at http://www.hhs.gov/ash/carb/.
    Members of the public will have the opportunity to provide comments 
prior to the Advisory Council meeting by emailing [email protected]. Public 
comments should be sent in by midnight September 19, 2018, and should 
be limited to no more than one page. All public comments received prior 
to September 19, 2018, will be provided to Advisory Council members; 
comments are limited to two minutes per speaker.

    Dated: August 21, 2018.
Jomana F. Musmar,
Acting Designated Federal Officer, Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria Committee Manager.
[FR Doc. 2018-18483 Filed 8-24-18; 8:45 am]
 BILLING CODE 4150-44-P

43692 Federal Register / Vol. 83, No. 166 / Monday, August 27, 2018 / Notices

ANNUAL BURDEN ESTIMATES
Number of Average
Number of Total burden
Instrument responses per burden hours
respondents hours
respondent per response

ADR ................................................................................................................. 275 1 1 275

Estimated Total Annual Burden the public comment session. Individuals for the formation and use of federal
Hours: 275. who wish to attend the meeting and/or advisory committees.
Additional Information: Copies of the send in their public comment via email The Advisory Council will provide
proposed collection may be obtained by should send an email to CARB@hhs.gov. advice, information, and
writing to the Administration for Registration information is available on recommendations to the Secretary of
Children and Families, Office of the website http://www.hhs.gov/ash/ HHS regarding programs and policies
Planning, Research and Evaluation, 330 carb/ and must be completed by intended to support and evaluate the
C Street SW, Washington, DC 20201. September 19, 2018; all in-person implementation of Executive Order
Attention Reports Clearance Officer. All attendees must pre-register by this date. 13676, including the National Strategy
requests should be identified by the title Additional information about registering for Combating Antibiotic-Resistant
of the information collection. Email for the meeting and providing public Bacteria and the National Action Plan
address: infocollection@acf.hhs.gov. comment can be obtained at http:// for Combating Antibiotic-Resistant
OMB Comment: OMB is required to www.hhs.gov/ash/carb/ on the Meetings Bacteria. The Advisory Council shall
make a decision concerning the page. function solely for advisory purposes.
collection of information between 30 In carrying out its mission, the
DATES: The meeting is scheduled to be Advisory Council will provide advice,
and 60 days after publication of this
held on September 26, 2018, from 9:00 information, and recommendations to
document in the Federal Register.
a.m. to 5:00 p.m. ET (times are tentative the Secretary regarding programs and
Therefore, a comment is best assured of
and subject to change). The confirmed policies intended to preserve the
having its full effect if OMB receives it
times and agenda items for the meeting effectiveness of antibiotics by
within 30 days of publication. Written
will be posted on the website for the optimizing their use; advance research
comments and recommendations for the
Advisory Council at http:// to develop improved methods for
proposed information collection should
www.hhs.gov/ash/carb/ when this combating antibiotic resistance and
be sent directly to the following: Office
information becomes available. Pre- conducting antibiotic stewardship;
of Management and Budget, Paperwork
registration for attending the meeting in strengthen surveillance of antibiotic-
Reduction Project, Email: OIRA_
person is required to be completed no resistant bacterial infections; prevent
SUBMISSION@OMB.EOP.GOV; Attn:
later than September 19, 2018; public the transmission of antibiotic-resistant
Desk Officer for the Administration for
attendance at the meeting is limited to bacterial infections; advance the
Children and Families.
the available space. development of rapid point-of-care and
Robert A. Sargis, ADDRESSES: This public meeting is being agricultural diagnostics; further research
Reports Clearance Officer. held at the Sheraton Columbus Hotel at on new treatments for bacterial
[FR Doc. 2018–18495 Filed 8–24–18; 8:45 am] Capitol Square, 75 East State Street, infections; develop alternatives to
BILLING CODE 4184–34–P Columbus, OH, 43215. The meeting can antibiotics for agricultural purposes;
also be accessed through a live webcast maximize the dissemination of up-to-
on the day of the meeting. For more date information on the appropriate and
DEPARTMENT OF HEALTH AND information, visit http://www.hhs.gov/ proper use of antibiotics to the general
HUMAN SERVICES ash/carb/. public and human and animal
FOR FURTHER INFORMATION CONTACT: healthcare providers; and improve
Meeting of the Presidential Advisory
Jomana Musmar, Acting Designated international coordination of efforts to
Council on Combating Antibiotic-
Federal Officer, Presidential Advisory combat antibiotic resistance.
Resistant Bacteria The September 26, 2018, public
Council on Combating Antibiotic-
AGENCY: Department of Health and Resistant Bacteria, Office of the meeting will be dedicated to the
Human Services, Office of the Secretary, Assistant Secretary for Health, U.S. Advisory Council’s deliberation and
Office of the Assistant Secretary for Department of Health and Human vote of the Infection Prevention and
Health. Services, Room 715H, Hubert H. Stewardship Working Group’s draft
ACTION: Notice. Humphrey Building, 200 Independence report with recommendations, in
Avenue SW, Washington, DC 20201. addition to other topic areas
SUMMARY: As stipulated by the Federal surrounding antibiotic-resistance and
Phone: (202) 690–5566; email: CARB@
Advisory Committee Act, the One Health. The meeting agenda will be
hhs.gov.
Department of Health and Human posted on the Advisory Council website
Services (HHS) is hereby giving notice SUPPLEMENTARY INFORMATION: Under at http://www.hhs.gov/ash/carb/ when it
that a meeting is scheduled to be held Executive Order 13676, dated has been finalized. All agenda items are
for the Presidential Advisory Council on September 18, 2014, authority was given tentative and subject to change.
amozie on DSK3GDR082PROD with NOTICES1

Combating Antibiotic-Resistant Bacteria to the Secretary of HHS to establish the Public attendance at the meeting is
(Advisory Council). The meeting will be Advisory Council, in consultation with limited to the available space.
open to the public; a public comment the Secretaries of Defense and Individuals who plan to attend and
session will be held during the meeting. Agriculture. Activities of the Advisory need special assistance, such as sign
Pre-registration is required for members Council are governed by the provisions language interpretation or other
of the public who wish to attend the of Public Law 92–463, as amended (5 reasonable accommodations, should
meeting and who wish to participate in U.S.C. App.), which sets forth standards notify the Advisory Council at the

VerDate Sep<11>2014 17:51 Aug 24, 2018 Jkt 244001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\27AUN1.SGM 27AUN1

Federal Register / Vol. 83, No. 166 / Monday, August 27, 2018 / Notices 43693

address/telephone number listed above Name of Committee: National Cancer Place: Bethesda Marriott Suites, 6711
at least one week prior to the meeting. Institute Special Emphasis Panel; SEP 4 for Democracy Boulevard, Bethesda, MD 20817.
For those unable to attend in person, a Provocative Questions. Contact Person: Byeong-Chel Lee, Ph.D.,
Date: September 21, 2018. Scientific Review Officer, Resources and
live webcast will be available. More Time: 7:30 a.m. to 6:00 p.m.
information on registration and Training Review Branch, Division of
Agenda: To review and evaluate grant
accessing the webcast can be found at applications. Extramural Activities, National Cancer
http://www.hhs.gov/ash/carb/. Place: Bethesda North Marriott Hotel & Institute, NIH, 9609 Medical Center Drive,
Members of the public will have the Conference Center, 5701 Marinelli Road, Room 7W238, Bethesda, MD 20892–9750,
opportunity to provide comments prior North Bethesda, MD 20852. 240–276–7755, byeong-chel.lee@nih.gov.
to the Advisory Council meeting by Contact Person: Clifford W. Schweinfest, Name of Committee: National Cancer
emailing CARB@hhs.gov. Public Ph.D., Scientific Review Officer, Special Institute Special Emphasis Panel; SEP–1 NCI
comments should be sent in by Review Branch, Division of Extramural
Clinical and Translational R21 and Omnibus
Activities, National Cancer Institute, NIH,
midnight September 19, 2018, and 9609 Medical Center Drive, Room 7W108, R03.
should be limited to no more than one Bethesda, MD 20892–9750, 240–276–6343, Date: October 25, 2018.
page. All public comments received schweinfestcw@mail.nih.gov. Time: 10:00 a.m. to 5:00 p.m.
prior to September 19, 2018, will be Name of Committee: National Cancer Agenda: To review and evaluate grant
provided to Advisory Council members; Institute Special Emphasis Panel; SEP–1 for applications.
comments are limited to two minutes Provocative Questions. Place: National Cancer Institute, Shady
per speaker. Date: October 4, 2018. Grove, 9609 Medical Center Drive, Room
Time: 7:30 a.m. to 4:00 p.m. 7W242, Rockville, MD 20850 (Telephone
Dated: August 21, 2018.
Agenda: To review and evaluate grant Conference Call).
Jomana F. Musmar, applications. Contact Person: Zhiqiang Zou, M.D., Ph.D.,
Acting Designated Federal Officer, Place: Cambria Hotel Rockville, 1 Helen
Scientific Review Officer, Special Review
Presidential Advisory Council on Combating Heneghan Way, Rockville, MD 20850.
Antibiotic-Resistant Bacteria Committee Contact Person: Hasan Siddiqui, Ph.D., Branch, Division of Extramural Activities,
Manager. Scientific Review Officer, Special Review National Cancer Institute, NIH, 9609 Medical
[FR Doc. 2018–18483 Filed 8–24–18; 8:45 am] Branch, Division of Extramural Activities, Center Drive, Room 7W242, Bethesda, MD
National Cancer Institute, NIH, 9609 Medical 20892–9750, 240–276–6372, zouzhiq@
BILLING CODE 4150–44–P
Center Drive, Room 7W240, Bethesda, MD mail.nih.gov.
20892–9750, 240–276–5122, hasan.siddiqui@ Name of Committee: National Cancer
nih.gov. Institute Special Emphasis Panel; NCI U01
DEPARTMENT OF HEALTH AND
Name of Committee: National Cancer Review: Integrating Biospecimens into
HUMAN SERVICES
Institute Special Emphasis Panel; SEP–3 for Clinical Assay Development.
Provocative Questions.
National Institutes of Health Date: November 15, 2018.
Date: October 9, 2018.
Time: 8:00 a.m. to 6:00 p.m. Time: 12:00 p.m. to 2:00 p.m.
National Cancer Institute; Notice of Agenda: To review and evaluate grant
Agenda: To review and evaluate grant
Closed Meetings applications. applications.
Pursuant to section 10(d) of the Place: Bethesda North Marriott Hotel & Place: National Cancer Institute, Shady
Federal Advisory Committee Act, as Conference Center, 5701 Marinelli Road, Grove, 9609 Medical Center Drive, Room
North Bethesda, MD 20852. 7W116, Rockville, MD 20850 (Telephone
amended, notice is hereby given of the Contact Person: Adriana Stoica, Ph.D.,
following meetings. Conference Call).
Scientific Review Officer, Resources and Contact Person: Klaus B. Piontek, Ph.D.,
The meetings will be closed to the Training Review Branch, Division of
public in accordance with the Scientific Review Officer, Research Programs
Extramural Activities, National Cancer
provisions set forth in sections Review Branch, Division of Extramural
Institute, NIH, 9609 Medical Center Drive,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Room 7W234, Bethesda, MD 20892–9750, Activities, National Cancer Institute, NIH,
240–276–6368, Stoicaa2@mail.nih.gov. 9609 Medical Center Drive, Room 7W116,
as amended. The grant applications and
Name of Committee: National Cancer Bethesda, MD 20892–9750, 240–276–7849,
the discussions could disclose
Institute Special Emphasis Panel; Traceback klaus.piontek@nih.gov.
confidential trade secrets or commercial
property such as patentable material, Testing: Identification and Genetic (Catalogue of Federal Domestic Assistance
Counseling of Mutation Carriers (U01). Program Nos. 93.392, Cancer Construction;
and personal information concerning
Date: October 10, 2018. 93.393, Cancer Cause and Prevention
individuals associated with grant Time: 11:00 a.m. to 1:00 p.m.
applications, the disclosure of which Research; 93.394, Cancer Detection and
Agenda: To review and evaluate grant Diagnosis Research; 93.395, Cancer
would constitute a clearly unwarranted applications.
invasion of personal privacy. Treatment Research; 93.396, Cancer Biology
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room Research; 93.397, Cancer Centers Support;
Name of Committee: National Cancer 93.398, Cancer Research Manpower; 93.399,
Institute Special Emphasis Panel; NCI SPORE 7W248, Rockville, MD 20850 (Telephone
Conference Call). Cancer Control, National Institutes of Health,
III.
Date: September 19–20, 2018. Contact Person: Anita T. Tandle, Ph.D., HHS)
Time: 5:00 p.m. to 5:00 p.m. Scientific Review Officer, Research Programs
Agenda: To review and evaluate grant Review Branch, Division of Extramural Dated: August 20, 2018.
applications. Activities, National Cancer Institute, NIH, Melanie J. Pantoja,
Place: Gaithersburg Marriott 9609 Medical Center Drive, Room 7W248,
Bethesda, MD 20892–9750, 240–276–5007, Program Analyst, Office of Federal Advisory
Washingtonian Center, 9751 Washingtonian Committee Policy.
amozie on DSK3GDR082PROD with NOTICES1

Boulevard, Gaithersburg, MD 20878. tandlea@mail.nih.gov.
Name of Committee: National Cancer [FR Doc. 2018–18399 Filed 8–24–18; 8:45 am]
Contact Person: Wlodek Lopaczynski,
M.D., Ph.D., Scientific Review Officer, Institute Special Emphasis Panel; SEP–5 for BILLING CODE 4140–01–P
Research Programs Review Branch, Division Provocative Questions.
of Extramural Activities, National Cancer Date: October 18–19, 2018.
Institute, NIH, 9609 Medical Center Drive, Time: 6:00 p.m. to 5:00 p.m.
Room 7W514, Bethesda, MD 20892–9750, Agenda: To review and evaluate grant
240–276–6340, lopacw@mail.nih.gov. applications.

VerDate Sep<11>2014 17:51 Aug 24, 2018 Jkt 244001 PO 00000 Frm 00060 Fmt 4703 Sfmt 9990 E:\FR\FM\27AUN1.SGM 27AUN1

Document Created: 2018-08-25 01:48:23
Document Modified: 2018-08-25 01:48:23

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		The meeting is scheduled to be held on September 26, 2018, from 9:00 a.m. to 5:00 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the website for the Advisory Council at http://www.hhs.gov/ash/carb/ when this information becomes available. Pre-registration for attending the meeting in person is required to be completed no later than September 19, 2018; public attendance at the meeting is limited to the available space.
Contact		Jomana Musmar, Acting Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic- Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: (202) 690-5566; email: [email protected]
FR Citation		83 FR 43692